Leiomyosarcoma diagnostics and treatment development program
Developmental Research Program
['FUNDING_OTHER'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-11193268
This program funds short projects that aim to find better ways to diagnose and treat leiomyosarcoma, a type of soft‑tissue cancer, to help patients and doctors.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-11193268 on ClinicalTrials.gov |
What this research studies
From a patient's view, this program supports small, fast projects that build the data needed to move discoveries toward clinics. It focuses on the genetics and genomics of leiomyosarcoma and funds work that could lead to new diagnostic tests or therapies. The program encourages established and new researchers to try translational approaches and may seed future clinical trials. Leadership spans major cancer centers and collaborates with clinicians who run sarcoma trials.
Who could benefit from this research
Good fit: Ideal candidates are people diagnosed with leiomyosarcoma who are willing to provide clinical data or biological samples or who may consider joining future sarcoma clinical trials.
Not a fit: People without leiomyosarcoma or those needing immediate standard-of-care treatment may not see direct benefit from this program right away.
Why it matters
Potential benefit: If successful, the program could lead to earlier diagnosis, more precise genomic-based treatments, or new clinical trial options for people with leiomyosarcoma.
How similar studies have performed: Genomic and translational approaches have produced useful diagnostics and targeted drugs in several cancers, but leiomyosarcoma-specific advances have been limited so this builds on known methods while seeking new discoveries.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROBINSON, STEVEN — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: ROBINSON, STEVEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Biology, Cancer Center